본문 바로가기
KERD
논문KCI 등재

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

초록

Mast cell increases and activation are detected in the chronic inflammatory bladder disease interstitial cystitis (IC), and their proinflammatory mediators are felt to contribute to regional pelvic pain and inflammatory pathophysiology. The immunoreceptor tyrosine-based inhibition motif-containing sialic acid-binding immunoglobulin-like lectins (Siglecs) expressed in mast cells could be evaluated as in vivo signaling regulators capable of inhibiting IC-related mast cell activation.

Abstract

Mast cell increases and activation are detected in the chronic inflammatory bladder disease interstitial cystitis (IC), and their proinflammatory mediators are felt to contribute to regional pelvic pain and inflammatory pathophysiology. The immunoreceptor tyrosine-based inhibition motif-containing sialic acid-binding immunoglobulin-like lectins (Siglecs) expressed in mast cells could be evaluated as in vivo signaling regulators capable of inhibiting IC-related mast cell activation.

참고문헌 (19)

  1. Theoharides TC, "Mast cell involvement in interstitial cystitis: a review of human and experimental evidence", Urology, 57(6 Suppl 1), pp.47~55 (2001)
  2. Rudick CN, "Mast cell-derived histamine mediates cystitis pain", PLoS One, 3, pp.e2096~ (2008)
  3. Simmons JL, "On the use of an antihistamine in the treatment of interstitial cystitis", Am Surg, 24, pp.664~667 (1958)
  4. Sakthivel SK, "CXCL10 blockade protects mice from cyclophosphamide-induced cystitis", J Immune Based Ther Vaccines, 6, pp.6~ (2008)
  5. Tomaszewski JE, "Biopsy features are associated with primary symptoms in interstitial cystitis: results from the interstitial cystitis database study", Urology, 57(6 Suppl 1), pp.67~81 (2001)
  6. el-Mansoury M, "Increased urine histamine and methylhistamine in interstitial cystitis", J Urol, 152(2 Pt 1), pp.350~353 (1994)
  7. Li L, "Mast cell and immune inhibitory receptors", Cell Mol Immunol, 1, pp.408~415 (2004)
  8. Richter B, "YKL-40 and mast cells are associated with detrusor fibrosis in patients diagnosed with bladder pain syndrome", interstitial cystitis according to the 2008 criteria of the European Society for the Study of Interstitial Cystitis, 2010, pp.57, 371~383
  9. Erickson DR, "Inflammatory cell types and clinical features of interstitial cystitis", J Urol, 158(3 Pt 1), pp.790~793 (1997)
  10. Bolland S, "Inhibitory pathways triggered by ITIM-containing receptors", Adv Immunol, 72, pp.149~177 (1999)
  11. Tamir I, "Cytoplasmic protein tyrosine phosphatases SHP-1 and SHP-2: regulators of B cell signal transduction", Curr Opin Immunol, 12, pp.307~315 (2000)
  12. Crocker PR, "Siglecs and their roles in the immune system", Nat Rev Immunol, 7, pp.255~266 (2007)
  13. von Gunten S, "Bochner BS. Basic and clinical immunology of Siglecs", Ann N Y Acad Sci, 1143, pp.61~82 (2008)
  14. O’Reilly MK, "Siglecs as targets for therapy in immune-cell-mediated disease", Trends Pharmacol Sci, 30, pp.240~248 (2009)
  15. Ghannadan M, "Detection of novel CD antigens on the surface of human mast cells and basophils", Int Arch Allergy Immunol, 127, pp.299~307 (2002)
  16. Yokoi H, "Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells", Allergy, 61, pp.769~776 (2006)
  17. Nutku E, "Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis", Blood, 101, pp.5014~5020 (2003)
  18. Yokoi H, "Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement", J Allergy Clin Immunol, 121, pp.499~505 (2008)
  19. Bochner BS, "Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors", Clin Exp Allergy, 39, pp.317~324 (2009)

관련 논문AI추천

이 간행물의 다른 논문 (9건)